Kiara Health raises Pre-Seed Funding to Build AI-Powered Fertility Platform

Kiara Health has secured an undisclosed pre-seed investment from Coyote Ventures to develop its AI-powered personalised fertility care platform, bringing together reproductive health data, clinical insights and personalised guidance in a single digital pathway.

Image used for illustrative purposes only
WT default author logo
Women's Tabloid News Desk

Kiara Health, a healthcare technology company founded by Milan Chavarkar and Priyanka Vaidya, has raised pre-seed funding from Coyote Ventures to advance its vision for more personalised and connected fertility care.

The company is developing a Fertility Intelligence Engine designed to combine clinical history, lifestyle information, biomarkers, laboratory data and evidence-based guidelines to generate personalised insights and care plans. The aim is to help people better understand their fertility and reproductive health before they enter more intensive treatment pathways. 

Bringing fragmented fertility care together

Fertility care can involve multiple providers, tests, data sources and decisions, often leaving patients to navigate a complex journey themselves.

Kiara Health is taking a different approach by building what it describes as a full-stack fertility platform. Its model begins with coaching and personalised insights before expanding into programmes, diagnostics and connections with healthcare providers and marketplace partners.

The company has already established data partnerships with Mira, Levels and Natera, bringing hormonal, metabolic and genetic information into its wider ecosystem. 

Coyote Ventures said Kiara’s platform is designed to create a more connected pathway spanning education, diagnostics, coaching, clinical care and ongoing optimisation.

AI at the centre of personalised reproductive health

At the heart of Kiara Health’s proposition is its use of artificial intelligence to interpret multiple sources of health information.

Rather than relying on a single data point, the company’s platform is designed to bring together clinical history, laboratory results, lifestyle factors and biomarkers to generate increasingly personalised insights.

The approach reflects a wider shift towards using technology to move healthcare beyond reactive treatment and towards earlier, more individualised intervention.

For fertility care in particular, this could mean giving people more information about their reproductive health before they reach the point of considering treatments such as IVF.

A broader reproductive health platform

Kiara Health’s ambitions extend beyond fertility alone.

Following the latest funding, the company plans to develop its platform across multiple reproductive life stages, including fertility optimisation, IVF preparation, pregnancy risk prediction, maternal health, postpartum care and menopause.

The longer-term vision is to create a longitudinal reproductive health platform that can support patients as their needs change, while also providing tools for clinicians, researchers, employers and healthcare systems.

Female entrepreneurship meets women’s health innovation

The company’s founding team also places female entrepreneurship at the centre of an increasingly important area of healthcare innovation.

Priyanka Vaidya, co-founder of Kiara Health, brings experience from founding Delfina Health and working as a Venture Partner at Coyote Ventures. Her co-founder, Milan Chavarkar, is a nurse practitioner and founder of Lotus Health.

Their work comes as investment and innovation in women’s health continue to expand, with fertility becoming an increasingly technology-driven area of healthcare.

For founders working in femtech, the challenge is not simply developing new technology. Building products that can connect patients, clinicians, diagnostics and health data requires a combination of healthcare expertise, technology and a clear understanding of the patient journey.

Building fertility care for the next generation

Kiara Health’s pre-seed funding gives the company an opportunity to further develop its technology and expand its approach to reproductive healthcare.

Its ambition is ultimately broader than creating another fertility app. By combining AI, health data, clinical expertise and personalised care, Kiara Health is attempting to build a more connected infrastructure for reproductive health.

As women’s health technology continues to evolve, Kiara Health represents a new generation of femtech businesses using AI to make complex healthcare journeys more personalised, informed and connected.

Share:

Related Insights

Sadia Haque: From Travel-Tech Entrepreneur to South Asia’s Voice for Women in Digital Business

Midi Health expands beyond Menopause Care with New Women’s Health Brand

Biograph expands Preventive Care with comprehensive Women’s Health Programme

Mindset launches Non-Profit Growth Program for Female Founders in Emerging Markets

Only 9 Women CEOs lead India’s Top 500 Companies. Why aren’t more reaching the top?

Beyond the headlines: What Lucy Davis’s cancer diagnosis teaches us about women’s health and workplace support

Calla Lily Clinical Care selected for $50 million Wellcome Leap antibiotics initiative

NVIDIA partners with global financial institutions to build AI compute financing platforms